comprehensive -WSS

comprehensive

author：fashion 2025-10-02 21:06:17 - browse：344

Teleflex announced plans on Wednesday to acquire Palette Life Sciences, the maker of a slate of gel-based products treating urological disorders. The vascular device manufacturer will pay $600 million upfront, and plans to use Palette’s portfolio to treat more urinary tract and reproductive health conditions.

Palette will bring Teleflex an extra $56 million in sales, the company estimated in a press release. Teleflex develops a range of devices, but makes the most money from vascular products like catheters. The company offers just one urological treatment: the UroLift system to relieve an enlarged prostate. With Palette, it will gain five more treatments all built from hyaluronic acid, a stretchy material that’s meant to last longer in the human body.

Palette’s highest-revenue device is Barrigel, which helps protect the rectum from harsh radiation administered to prostate cancer patients. It eases symptoms like bladder inflammation, bleeding, and diarrhea. The device received FDA clearance in May 2022 through the 510(k) process, which allowed Palette to claim the product was equivalent to a rectal radiation protector sold by Boston Scientific. Boston Scientific has sold that device since 2018, when it acquired it by buying the startup Augmenix for $500 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Why sickle cell disease is getting the first CRISPR treatment

WSS

What is artificial intelligence? Experts weigh in

What is artificial intelligence? Experts weigh in

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

EMA weighs against approval for Mirati's lung cancer drug

SCOTUS to consider access to abortion pill mifepristone

What causes an itch? Researchers may have solved the mystery

focus

comprehensive

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

The woman behind the Dana Farber

Anesthesiologist group: stop taking Ozempic before surgery

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Hepatitis C has a cure — but many Americans still lack access to it

Chemotherapy shortages won’t get better under Biden’s latest plan

The cancer drug shortage isn’t new — and neither are the solutions

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

entertainment

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

Pharma patents targeted by Biden in move to slash drug prices

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Supreme Court wrestles with OxyContin maker's bankruptcy deal

focus

hotspot

knowledge

hotspot